PFG Private Wealth Management LLC Acquires Shares of 2,533 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

PFG Private Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,533 shares of the company’s stock, valued at approximately $198,000.

Several other hedge funds also recently modified their holdings of the stock. Raymond James Financial Inc. purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $73,472,000. Cullen Frost Bankers Inc. boosted its position in shares of GE HealthCare Technologies by 55.7% during the fourth quarter. Cullen Frost Bankers Inc. now owns 13,714 shares of the company’s stock valued at $1,072,000 after buying an additional 4,908 shares during the last quarter. Arizona State Retirement System boosted its position in shares of GE HealthCare Technologies by 4.5% during the fourth quarter. Arizona State Retirement System now owns 129,811 shares of the company’s stock valued at $10,149,000 after buying an additional 5,610 shares during the last quarter. Verdence Capital Advisors LLC boosted its position in shares of GE HealthCare Technologies by 13.1% during the fourth quarter. Verdence Capital Advisors LLC now owns 4,149 shares of the company’s stock valued at $324,000 after buying an additional 480 shares during the last quarter. Finally, Proficio Capital Partners LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $7,775,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on GEHC shares. Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $84.76 on Thursday. The firm has a market cap of $38.76 billion, a PE ratio of 19.58, a PEG ratio of 3.19 and a beta of 1.15. The stock’s fifty day moving average price is $86.52 and its two-hundred day moving average price is $86.13. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.